127 related articles for article (PubMed ID: 17554374)
1. Segmental uniparental disomy as a recurrent mechanism for homozygous CEBPA mutations in acute myeloid leukemia.
Wouters BJ; Sanders MA; Lugthart S; Geertsma-Kleinekoort WM; van Drunen E; Beverloo HB; Löwenberg B; Valk PJ; Delwel R
Leukemia; 2007 Nov; 21(11):2382-4. PubMed ID: 17554374
[No Abstract] [Full Text] [Related]
2. Association between acquired uniparental disomy and homozygous gene mutation in acute myeloid leukemias.
Fitzgibbon J; Smith LL; Raghavan M; Smith ML; Debernardi S; Skoulakis S; Lillington D; Lister TA; Young BD
Cancer Res; 2005 Oct; 65(20):9152-4. PubMed ID: 16230371
[TBL] [Abstract][Full Text] [Related]
3. Identification of acquired copy number alterations and uniparental disomies in cytogenetically normal acute myeloid leukemia using high-resolution single-nucleotide polymorphism analysis.
Bullinger L; Krönke J; Schön C; Radtke I; Urlbauer K; Botzenhardt U; Gaidzik V; Carió A; Senger C; Schlenk RF; Downing JR; Holzmann K; Döhner K; Döhner H
Leukemia; 2010 Feb; 24(2):438-49. PubMed ID: 20016533
[TBL] [Abstract][Full Text] [Related]
4. Combined testing for CCAAT/enhancer-binding protein alpha (CEBPA) mutations and promoter methylation in acute myeloid leukemia demonstrates shared phenotypic features.
Szankasi P; Ho AK; Bahler DW; Efimova O; Kelley TW
Leuk Res; 2011 Feb; 35(2):200-7. PubMed ID: 20970189
[TBL] [Abstract][Full Text] [Related]
5. Uniparental disomy may be associated with microsatellite instability in acute myeloid leukemia (AML) with a normal karyotype.
Serrano E; Carnicer MJ; Orantes V; Estivill C; Lasa A; Brunet S; Aventín AM; Sierra J; Nomdedéu JF
Leuk Lymphoma; 2008 Jun; 49(6):1178-83. PubMed ID: 18452069
[TBL] [Abstract][Full Text] [Related]
6. K313dup is a recurrent CEBPA mutation in de novo acute myeloid leukemia (AML).
Carnicer MJ; Lasa A; Buschbeck M; Serrano E; Carricondo M; Brunet S; Aventin A; Sierra J; Di Croce L; Nomdedeu JF
Ann Hematol; 2008 Oct; 87(10):819-27. PubMed ID: 18587575
[TBL] [Abstract][Full Text] [Related]
7. Segmental uniparental disomy is a commonly acquired genetic event in relapsed acute myeloid leukemia.
Raghavan M; Smith LL; Lillington DM; Chaplin T; Kakkas I; Molloy G; Chelala C; Cazier JB; Cavenagh JD; Fitzgibbon J; Lister TA; Young BD
Blood; 2008 Aug; 112(3):814-21. PubMed ID: 18490517
[TBL] [Abstract][Full Text] [Related]
8. Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia.
Pabst T; Eyholzer M; Haefliger S; Schardt J; Mueller BU
J Clin Oncol; 2008 Nov; 26(31):5088-93. PubMed ID: 18768433
[TBL] [Abstract][Full Text] [Related]
9. Complexity of CEBPA dysregulation in human acute myeloid leukemia.
Pabst T; Mueller BU
Clin Cancer Res; 2009 Sep; 15(17):5303-7. PubMed ID: 19706798
[TBL] [Abstract][Full Text] [Related]
10. Role of CEBPA in normal karyotype acute myeloid leukemia.
Medeiros BC
J Clin Oncol; 2009 Apr; 27(12):2105; author reply 2106. PubMed ID: 19273693
[No Abstract] [Full Text] [Related]
11. GATA2 mutations are frequent in intermediate-risk karyotype AML with biallelic CEBPA mutations and are associated with favorable prognosis.
Fasan A; Eder C; Haferlach C; Grossmann V; Kohlmann A; Dicker F; Kern W; Haferlach T; Schnittger S
Leukemia; 2013 Feb; 27(2):482-5. PubMed ID: 22814295
[No Abstract] [Full Text] [Related]
12. MicroRNA let-7a-3 gene methylation is associated with karyotyping, CEBPA promoter methylation, and survival in acute myeloid leukemia.
Ko YC; Fang WH; Lin TC; Hou HA; Chen CY; Tien HF; Lin LI
Leuk Res; 2014 May; 38(5):625-31. PubMed ID: 24703161
[TBL] [Abstract][Full Text] [Related]
13. Multiplex high-throughput gene mutation analysis in acute myeloid leukemia.
Dunlap J; Beadling C; Warrick A; Neff T; Fleming WH; Loriaux M; Heinrich MC; Kovacsovics T; Kelemen K; Leeborg N; Gatter K; Braziel RM; Press R; Corless CL; Fan G
Hum Pathol; 2012 Dec; 43(12):2167-76. PubMed ID: 22658276
[TBL] [Abstract][Full Text] [Related]
14. Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients.
Dufour A; Schneider F; Hoster E; Benthaus T; Ksienzyk B; Schneider S; Kakadia PM; Sauerland MC; Berdel WE; Büchner T; Wörmann B; Braess J; Subklewe M; Hiddemann W; Bohlander SK; Spiekermann K;
Ann Hematol; 2012 Jul; 91(7):1051-63. PubMed ID: 22362118
[TBL] [Abstract][Full Text] [Related]
15. Single nucleotide polymorphism microarray analysis of karyotypically normal acute myeloid leukemia reveals frequent copy number neutral loss of heterozygosity.
Tyybäkinoja A; Elonen E; Vauhkonen H; Saarela J; Knuutila S
Haematologica; 2008 Apr; 93(4):631-2. PubMed ID: 18379011
[No Abstract] [Full Text] [Related]
16. CEBPA polymorphisms and mutations in patients with acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and non-Hodgkin's lymphoma.
Fuchs O; Provaznikova D; Kocova M; Kostecka A; Cvekova P; Neuwirtova R; Kobylka P; Cermak J; Brezinova J; Schwarz J; Markova J; Salaj P; Klamova H; Maaloufova J; Lemez P; Novakova L; Benesova K
Blood Cells Mol Dis; 2008; 40(3):401-5. PubMed ID: 18182175
[TBL] [Abstract][Full Text] [Related]
17. Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2.
Snaddon J; Smith ML; Neat M; Cambal-Parrales M; Dixon-McIver A; Arch R; Amess JA; Rohatiner AZ; Lister TA; Fitzgibbon J
Genes Chromosomes Cancer; 2003 May; 37(1):72-8. PubMed ID: 12661007
[TBL] [Abstract][Full Text] [Related]
18. A copy number repeat polymorphism in the transactivation domain of the CEPBA gene is possibly associated with a protective effect against acquired CEBPA mutations: an analysis in 1135 patients with AML and 187 healthy controls.
Schnittger S; Bacher U; Eder C; Lohse P; Haferlach C; Kern W; Haferlach T
Exp Hematol; 2011 Jan; 39(1):87-94. PubMed ID: 20888888
[TBL] [Abstract][Full Text] [Related]
19. Poor prognosis in familial acute myeloid leukaemia with combined biallelic CEBPA mutations and downstream events affecting the ATM, FLT3 and CDX2 genes.
Carmichael CL; Wilkins EJ; Bengtsson H; Horwitz MS; Speed TP; Vincent PC; Young G; Hahn CN; Escher R; Scott HS
Br J Haematol; 2010 Aug; 150(3):382-5. PubMed ID: 20456351
[No Abstract] [Full Text] [Related]
20. Molecular characterization of acute myeloid leukemia.
Döhner K; Döhner H
Haematologica; 2008 Jul; 93(7):976-82. PubMed ID: 18591623
[No Abstract] [Full Text] [Related]
[Next] [New Search]
